Molecular BiologybioRxivPreprint
Treatment of non-alcoholic steatohepatitis with recombinant Orosomucoid 2, an acute phase protein that attenuates the Erk1/2-PPARγ-Cd36 signaling pathway
Li Li, Haoming Sun, Jionghao Chen…·Qingzhu Sun
This study shows that recombinant Orm2 treatment reduces hepatic steatosis, inflammation, and fibrosis in NASH models by inhibiting the Erk1/2-PPARγ-Cd36 pathway.
1 citation